Right people, right solutions
Trust. Partnership. Quality.
TFS Neuroscience provides full-service support to clients from early phase through phase III, post-authorization and real-world studies. Our global operations teams are experienced in the unique challenges posed by neurology, psychiatry, and pain studies.
We partner with our clients to deliver tailored solutions that match their needs, when and where they need them.
TFS Neuroscience at a glance
Nearly 150 studies (neurology, psychiatry, and pain)
Over 50 ongoing projects
Nearly 40 Psychiatric and Pain studies
More than 1,000 specialized sites in the last 5 years
More than 12,000 patients in the last 5 years
TFS has broad experience across a range of neuroscience indications
- Alzheimer's Disease
- Amyotrophic Lateral Sclerosis (ALS)
- Cognitive Impairment
- Duchenne Muscular Dystrophy (DMD)
- Huntington’s Disease
- Headache – Cluster, Migraine
- Myasthenia Gravis
- Multiple Sclerosis (MS), including Relapsing Remitting MS (RRMS)
- Parkinson’s Disease
- Traumatic Brain Injury
Non-neurology, Psychiatry & Pain
- Chronic Fatigue Syndrome
- Circadian Rhythm Sleep Disorders
- Conduct Disorder
- Smoking Cessation
- Pain (Back, Cancer, Dental, Headache, HIV, Neuropathic)
- Major Depressive Disorder (MDD)
Partnerships that provide an advantage
TFS is aligned with several neurology-specialized academic research organizations, patient advocacy organizations, and consultancies in Europe and the US that can advise and support studies when needed.
One project, one team
The TFS Neuroscience team understands the complexities of clinical development and can partner with you to tailor a solution that helps ensure your project’s success. Working together maximizes the chances of success, and when we work with you, our knowledge and resources can be applied to your trial.
Anne-Marie joined TFS in September 2021 to lead the company’s Internal Medicine and Neurosciences Business Units. Her strategic and operational experience from nearly 25 years’ at both mid- and large-sized pharmaceutical and clinical research organizations will benefit biotech clients throughout their clinical development journey. Extensive experience in neuroscience with broad indications such as those in psychiatry (schizophrenia, MDD, bipolar disorders, anxiety) and neurology including rare and gene therapy (spasticity, cervical dystonia, rare and non rare epilepsy, Alzheimer’s, Parkinson’s and multiple sclerosis, neuromuscular disorders , Friedreich ataxia, Rett syndrome) .
Anne-Marie Nagy, PhD
Head of Internal Medicine and Neurosciences
- Specialized internal medicine indications in women health and pulmonary inflammatory diseases
- Operational oversight of large clinical programs in neurology, psychiatry, pain and cystic fibrosis across all phases in NA, EMEA, South Africa, ASIAPAC and LA, as well as peri-post approval drug market
Anne-Marie holds a PhD degree in Biomedical Sciences from the Faculty of Medicine of the Free University of Brussels, Belgium. She has received numerous academic honors and has authored several scientific publications in Reproductive Endocrinology and pulmonary inflammatory diseases.
All this know-how could be supporting your next trial – from design to completion. Contact us to see how we can enhance your resources with our expertise.
Let’s get your solution to market.